Vidisheva, Aleksandra P <br/><br/>
Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  10 2017 
 - 3217-3224 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-017-3732-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Bortezomib--administration & dosage<br/>Female<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--complications<br/>Peripheral Nervous System Diseases--drug therapy<br/>Recurrence<br/>Retreatment<br/>Retrospective Studies<br/>Risk Factors<br/>Severity of Illness Index<br/>Treatment Outcome